Aspire Biopharma Holdings, Inc. (ASBP) Revenue History
Annual and quarterly revenue from 2022 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
ASBP Revenue Analysis (2022–2024)
As of March 5, 2026, Aspire Biopharma Holdings, Inc. (ASBP) generated trailing twelve-month (TTM) revenue of $1,941. The most recent quarter (Q3 2025) recorded $1,941 in revenue.
Looking at the longer-term picture, ASBP's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including CAI (+144.9% YoY), VCYT (+16.0% YoY), and ADPT (+42.6% YoY). Compare ASBP vs CAI →
Peer Comparison
Compare ASBP's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ASBPCurrent | $1,941 | - | - | - | |
 CAI | $812M | +144.9% | +14.3% | 5.6% | |
 VCYT | $517M | +16.0% | +34.5% | 11.2% | |
 ADPT | $179M | +42.6% | +16.0% | -90.8% | |
 CDIO | $34,890 | -55.8% | - | -23977.9% | |
 SEER | $14M | +14.5% | +160.6% | -717.7% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $0 | - | $-3,088,671 | - |
| 2023 | $0 | - | $0 | - | $-358,590 | - |
| 2022 | $0 | - | $0 | - | $-596,491 | - |
See ASBP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ASBP Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare ASBP vs LLY
See how ASBP stacks up against sector leader Eli Lilly and Company.
Start ComparisonFrequently Asked Questions
Is ASBP's revenue growth accelerating or slowing?
ASBP TTM revenue: $1941.00. YoY growth: N/A. 5-year CAGR: N/A.
What is ASBP's long-term revenue growth rate?
Aspire Biopharma Holdings, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is ASBP's revenue distributed by segment?
ASBP reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2022-2024 are available for download. Segment mix reveals concentration and diversification trends.